Paraneoplastic Cerebellar Degeneration Accompanied by Seropositivity for Anti-GAD65, Anti-SOX-1 and Anti-VGCC Antibodies Due to Small-cell Lung Cancer

Intern Med. 2024 Mar 15;63(6):857-860. doi: 10.2169/internalmedicine.0738-22. Epub 2023 Aug 16.

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic neurological syndrome that is rarely accompanied by seropositivity with a combination of multiple antibodies. We herein report a 50-year-old man with PCD accompanied by small-cell lung cancer (SCLC). This patient was seropositive for anti-glutamic acid decarboxylase 65, anti-SRY-related HMG-box gene 1 and anti-voltage-gated calcium channel antibodies. After chemoradiation therapy without immunotherapy, cerebellar ataxia of the trunk and limbs markedly improved, along with a notable amelioration of SCLC. This case suggests that tumor therapy should be started immediately and that a panel of anti-neuronal antibodies should be evaluated when PCD with SCLC is suspected.

Keywords: anti-GAD65 antibody; anti-SOX-1 antibody; anti-VGCC antibody; paraneoplastic cerebellar degeneration; small-cell lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Antibodies
  • Autoantibodies
  • Chemoradiotherapy
  • Humans
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / therapy
  • Male
  • Middle Aged
  • Paraneoplastic Cerebellar Degeneration*
  • Small Cell Lung Carcinoma* / complications
  • Small Cell Lung Carcinoma* / therapy

Substances

  • Antibodies
  • Autoantibodies